88.80
Finanzdaten der Nutex Health Inc-Aktie (NUTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
43.36%
151.68
|
267.80 | 243.99 | 211.79 | 257.62 |
| Cost Of Revenue |
6.54%
105.54
|
112.92 | 119.06 | 93.45 | 115.99 |
| Gross Profit |
70.21%
46.14
|
154.88 | 124.92 | 118.34 | 141.63 |
| Operating Expenses |
37.91%
15.22
|
24.51 | 91.25 | 46.13 | 27.42 |
| Benefits Costs and Expenses |
12.57%
125.78
|
143.87 | 220.25 | 149.03 | 149.04 |
| Costs And Expenses |
6.54%
105.54
|
112.92 | 119.06 | 93.45 | 149.04 |
| Operating Income/Loss |
76.28%
30.92
|
130.37 | 33.68 | 72.21 | 114.21 |
| Income/Loss From Continuing Operations Before Tax |
79.11%
25.89
|
123.94 | 23.73 | 62.76 | 108.58 |
| Income Tax Expense/Benefit, Deferred |
121.10%
-5.866
|
27.81 | -2.365 | -2.50 | -11.39 |
| Income Tax Expense/Benefit |
65.78%
9.286
|
27.14 | 7.588 | 18.54 | 8.6087 |
| Income/Loss From Continuing Operations After Tax |
82.84%
16.61
|
96.80 | 16.14 | 50.81 | 99.97 |
|
|
82.84%
16.61
|
96.80 | 16.14 | 50.81 | 99.97 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
88.46%
4.774
|
41.36 | 33.84 | 29.59 | 38.27 |
| Basic Average Shares |
96.47%
0.2366
|
6.7012 | 5.9949 | 5.517 | 0.1173 |
| Diluted Average Shares |
99.71%
0.0212
|
7.1775 | 5.9949 | 5.8533 | - |
| Basic Earnings Per Share |
81.86%
1.50
|
8.27 | -2.95 | 2.65 | 11.83 |
| Diluted Earnings Per Share |
79.25%
1.61
|
7.76 | -2.95 | 2.56 | 11.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):